News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,006 Results
Type
Article (14175)
Company Profile (282)
Press Release (251549)
Section
Business (79543)
Career Advice (153)
Deals (13240)
Drug Delivery (36)
Drug Development (50453)
Employer Resources (31)
FDA (5717)
Job Trends (5134)
News (144474)
Policy (10045)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (911)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21647)
ALS (57)
Alzheimer's disease (813)
Antibody-drug conjugate (ADC) (79)
Approvals (5725)
Artificial intelligence (106)
Autoimmune disease (8)
Automation (5)
Bankruptcy (104)
Best Places to Work (4566)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (135)
Cancer (1191)
Cardiovascular disease (96)
Career advice (132)
Career pathing (2)
CAR-T (102)
Cell therapy (295)
Cervical cancer (5)
Clinical research (40768)
Collaboration (478)
Compensation (206)
Complete response letters (13)
COVID-19 (1032)
CRISPR (35)
C-suite (131)
Cystic fibrosis (75)
Data (1244)
Denatured (11)
Depression (28)
Diabetes (114)
Diagnostics (1290)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (75)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (66)
Earnings (29466)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (47975)
Executive appointments (384)
FDA (6285)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (440)
Gene editing (84)
Generative AI (10)
Gene therapy (219)
GLP-1 (345)
Government (1076)
Grass and pollen (3)
Guidances (18)
Healthcare (6601)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (73)
Indications (17)
Infectious disease (1088)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (52)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (198)
Leadership (2)
Legal (1387)
Liver cancer (30)
Lung cancer (169)
Lymphoma (80)
Machine learning (1)
Management (7)
Manufacturing (111)
MASH (46)
Medical device (2589)
Medtech (2590)
Mergers & acquisitions (6245)
Metabolic disorders (345)
Multiple sclerosis (48)
NASH (13)
Neurodegenerative disease (53)
Neuropsychiatric disorders (22)
Neuroscience (1162)
NextGen: Class of 2025 (2015)
Non-profit (853)
Northern California (1453)
Now hiring (21)
Obesity (181)
Opinion (100)
Ovarian cancer (50)
Pain (39)
Pancreatic cancer (49)
Parkinson's disease (99)
Partnered (6)
Patents (101)
Patient recruitment (60)
Peanut (35)
People (25467)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14384)
Phase II (18962)
Phase III (11999)
Pipeline (604)
Podcasts (43)
Policy (34)
Postmarket research (853)
Preclinical (6020)
Press Release (30)
Prostate cancer (50)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (265)
Real estate (1416)
Recruiting (12)
Regulatory (8525)
Reports (14)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (85)
Series B (53)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1290)
Special edition (11)
Sponsored (11)
Startups (1970)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (32)
United States (11470)
Vaccines (198)
Venture capitalists (27)
Webinars (7)
Weight loss (101)
Women's health (14)
Worklife (2)
Date
Last 7 days (341)
Last 30 days (1547)
Last 365 days (20111)
2025 (3854)
2024 (20586)
2023 (22431)
2022 (26842)
2021 (27833)
2020 (23377)
2019 (16255)
2018 (11769)
2017 (13771)
2016 (11853)
2015 (14367)
2014 (10406)
2013 (7500)
2012 (7541)
2011 (7629)
2010 (7432)
Location
Africa (148)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17179)
Australia (2912)
California (3321)
Canada (1023)
China (295)
Colorado (127)
Connecticut (141)
Delaware (84)
Europe (37006)
Florida (386)
Georgia (99)
Idaho (16)
Illinois (203)
India (7)
Indiana (83)
Iowa (1)
Japan (65)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (428)
Massachusetts (2621)
Michigan (69)
Minnesota (129)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (13)
New Jersey (835)
New Mexico (12)
New York (912)
North Carolina (502)
North Dakota (4)
Northern California (1453)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (631)
Puerto Rico (2)
Rhode Island (13)
South America (208)
South Carolina (3)
Southern California (1290)
Tennessee (24)
Texas (372)
Utah (49)
Virginia (66)
Washington D.C. (27)
Washington State (308)
Wisconsin (13)
266,006 Results for "ait therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Stallergenes Greer Publishes in the Lancet Regional Health-Europe Landmark EfficAPSI Real-world Study Confirming Significant Benefit of Its Liquid Sublingual AIT on the Onset and Progression of Allergic Asthma
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy, announced that results of its EfficAPSI real-world study evaluating the impact of Stallergenes Greer liquid sublingual AIT on asthma onset and evolution in patients with allergic rhinitis have been published in the Lancet Regional Health-Europe.
May 2, 2024
·
9 min read
Drug Development
AI Therapeutics Announces Positive Results from Phase 2a Biomarker-driven Trial of AIT-101 in Patients with C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today positive results from a Phase 2a clinical trial of AIT-101 (LAM-002A)1 in patients with C9ORF72 amyotrophic lateral sclerosis (ALS)2.
April 5, 2023
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Drug Development
Stallergenes Greer Announces Publication of Positive Results for PALFORZIA® Phase 3 Study in Peanut-allergic Children Aged 1 to 3 Years
Stallergenes Greer, a leading global healthcare company specialising in allergen immunotherapy (AIT), announces the publication of results from the Phase 3 POSEIDON (Peanut Oral Immunotherapy Study of Early Intervention for Desensitization) study in the New England Journal of Medicine Evidence.
November 20, 2023
·
6 min read
Biotech Beach
Calibre Scientific Expands European Presence and Chromatography Offering With AIT France Acquisition
Calibre Scientific is pleased to announce the acquisition of AIT France, a manufacturer and distributor of innovative consumables for analytical chemistry and chromatography.
January 25, 2021
·
1 min read
Press Releases
Allogene Therapeutics Announces Participation in March Investor Conference
February 26, 2025
·
2 min read
Press Releases
YourChoice Therapeutics Announces Nature Publication
March 13, 2025
·
4 min read
Press Releases
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
March 5, 2025
·
1 min read
Press Releases
C4 Therapeutics to Participate in Upcoming March Investor Conferences
February 24, 2025
·
1 min read
1 of 26,601
Next